Search

  6. ProQR to Present at Two Upcoming Investor Conferences in March

    Press release

    LEIDEN, the Netherlands, March 01, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases including cystic fibrosis (CF), Leber's congenital

  8. ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO)

    Press release

    … ProQR Announces Virtual Presentations at American Academy of … & CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Academy of Ophthalmology (AAO) held November 13-15, 2020. ProQR’s presentations Presentation title: Phase 1b/2 trial …

  9. ProQR to Present at the RBC Capital Markets Healthcare Conference

    Press release

    LEIDEN, the Netherlands and CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced